Group One Trading, L.P. Amylyx Pharmaceuticals, Inc. Transaction History
Group One Trading, L.P.
- $3.01 Billion
- Q2 2024
A detailed history of Group One Trading, L.P. transactions in Amylyx Pharmaceuticals, Inc. stock. As of the latest transaction made, Group One Trading, L.P. holds 289,281 shares of AMLX stock, worth $1.83 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
289,281
Previous 222,722
29.88%
Holding current value
$1.83 Million
Previous $632,000
13.13%
% of portfolio
0.02%
Previous 0.02%
Shares
10 transactions
Others Institutions Holding AMLX
# of Institutions
140Shares Held
46.4MCall Options Held
226KPut Options Held
909K-
Vanguard Group Inc Valley Forge, PA4.22MShares$26.7 Million0.0% of portfolio
-
Aqr Capital Management LLC Greenwich, CT3.34MShares$21.1 Million0.01% of portfolio
-
Black Rock Inc. New York, NY2.67MShares$16.9 Million0.0% of portfolio
-
Goldman Sachs Group Inc New York, NY2.61MShares$16.5 Million0.0% of portfolio
-
Abrdn PLC1.97MShares$12.5 Million0.01% of portfolio
About Amylyx Pharmaceuticals, Inc.
- Ticker AMLX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 58,533,200
- Market Cap $371M
- Description
- Amylyx Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, engages in developing various therapeutics for amyotrophic lateral sclerosis (ALS) and other neurodegenerative diseases. The company's product pipeline includes AMX0035, a dual UPR-Bax apoptosis inhibitor composed of sodium phenylbutyrate and taurursodiol for the treatment...